Corrigendum: Rationale and Design of a Pharmacist-led Intervention for the Risk-Based Prevention of Heart Failure: The FIT-HF Pilot Study

Front Cardiovasc Med. 2022 Feb 18:9:844270. doi: 10.3389/fcvm.2022.844270. eCollection 2022.

Michael C Wang¹, Bridget Dolan², Benjamin H Freed³, Lourdes Vega², Nikola Markoski², Amy E Wainright², Bonnie Kane¹, Laura E Seegmiller¹, Katharine Harrington¹, Alana A Lewis³, Sanjiv J Shah^{1

3}, Clyde W Yancy³, Ian J Neeland^{4

5}, Hongyan Ning¹, Donald M Lloyd-Jones^{1

3}, Sadiya S Khan^{1

3}

¹ Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, United States.
² Department of Pharmacy, Northwestern Memorial Hospital, Chicago, IL, United States.
³ Division of Cardiology, Northwestern University Feinberg School of Medicine, Chicago, IL, United States.
⁴ Department of Medicine, University Hospitals Cleveland Medical Center, Cleveland, OH, United States.
⁵ Case Western Reserve University School of Medicine, Cleveland, OH, United States.

Abstract

[This corrects the article DOI: 10.3389/fcvm.2021.785109.].

Keywords: heart failure; natriuretic peptides; pharmacist; primary prevention; risk prediction.